Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New eyelid wipe aims to soothe dry eyes

NCT ID NCT06400459

Symptom relief Sponsor: IVIEW Therapeutics Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new medicated eyelid wipe called IVW-1001 in 150 adults with dry eye disease. Participants used either a low dose, a higher dose, or a placebo wipe. The goal was to see if the wipe is safe and can improve tear production and eye comfort.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
IVW-1001 (a drug applied via eyelid wipe)
What this could lead to
If it works, this could provide a new, easy-to-use treatment option for people with dry eye disease.
What could go wrong
This is an early-phase trial with only 150 participants, so results may not apply to everyone. The treatment is still being tested for safety and effectiveness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 1/2

Runs two stages together: safety and dose first, then whether the treatment works.

Participants

150 people

The number who actually took part.

Started

Jun 2024

Finished

Oct 2024

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Subjects of any gender at least 18 years of age at the Screening Visit 2. Able to voluntarily provide written informed consent to participate in the study 3. Able and willing to comply with all study procedures and restrictions, follow study instructions, and complete required study visits 4. Diagnosis of Dry Eye Disease (DED) Exclusion Criteria: 1. Corneal fluorescein staining score of 4 using the NEI grading system 2. Intraocular pressure ≥23 mmHg 3. History of glaucoma or ocular hypertension in either eye requiring past or current medical or surgical intervention 4. Subjects with ocular inflammatory conditions (eg, conjunctivitis, keratitis, severe anterior blepharitis, etc.) not related to DED

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Dry eye disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

dry eye syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Dry eye disease

Contacts and locations

Locations

  • Houston Eye Associates

    Houston, Texas, 77025, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.